ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 79 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,153,000 | +3.3% | 68,213 | +0.3% | 0.00% | 0.0% |
| Q3 2016 | $1,116,000 | +8.1% | 68,023 | -0.2% | 0.00% | 0.0% |
| Q2 2016 | $1,032,000 | +43.3% | 68,141 | +36.9% | 0.00% | 0.0% |
| Q1 2016 | $720,000 | -37.6% | 49,776 | +22.3% | 0.00% | 0.0% |
| Q4 2015 | $1,153,000 | +70.1% | 40,708 | +0.5% | 0.00% | 0.0% |
| Q3 2015 | $678,000 | -34.0% | 40,504 | +3.4% | 0.00% | 0.0% |
| Q2 2015 | $1,027,000 | +584.7% | 39,158 | +356.9% | 0.00% | – |
| Q1 2015 | $150,000 | +1.4% | 8,570 | +0.7% | 0.00% | – |
| Q4 2014 | $148,000 | -6.3% | 8,512 | 0.0% | 0.00% | – |
| Q3 2014 | $158,000 | +11.3% | 8,512 | +9.4% | 0.00% | – |
| Q2 2014 | $142,000 | – | 7,781 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,423,578 | $8,826,000 | 6.08% |
| Healthcare Value Capital, LLC | 200,000 | $1,240,000 | 2.33% |
| ARMISTICE CAPITAL, LLC | 2,700,000 | $16,740,000 | 1.06% |
| DELTEC ASSET MANAGEMENT LLC | 550,836 | $3,415,000 | 0.75% |
| Broadfin Capital, LLC | 441,088 | $2,735,000 | 0.60% |
| Kerrisdale Advisers, LLC | 229,347 | $1,422,000 | 0.51% |
| Worth Venture Partners, LLC | 87,908 | $545,000 | 0.30% |
| Mosaic Family Wealth, LLC | 91,314 | $566,000 | 0.24% |
| EMERALD ADVISERS, LLC | 700,176 | $4,341,000 | 0.17% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 616,664 | $3,823,000 | 0.15% |